US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, Park Institute for Cancer Immunotherapy on Nov. 11 for "Engineered proteins to enhance sensitivity of a cell to IL-2" (California Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,868, issued on Nov. 11, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and Park Institute for Cancer Immunotherapy (San Francisco).

"Engineered proteins to enhance sensitivity of a cell to IL-2" was invented by Kenan Christopher Garcia (Menlo Park, Calif.), Sean Parker (Palo Alto, Calif.), Jonathan Sockolosky (San Francisco) and Michael Hollander (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered proteins, polynucleotides encoding such proteins, and methods of use thereof are provided, which engineered proteins enhance the sensitivity of a cell to IL-2."

The patent was file...